PL2844226T3 - Kompozycje okulistyczne o ulepszonej ochronie przed wysychaniem i zatrzymywaniu - Google Patents

Kompozycje okulistyczne o ulepszonej ochronie przed wysychaniem i zatrzymywaniu

Info

Publication number
PL2844226T3
PL2844226T3 PL13723623T PL13723623T PL2844226T3 PL 2844226 T3 PL2844226 T3 PL 2844226T3 PL 13723623 T PL13723623 T PL 13723623T PL 13723623 T PL13723623 T PL 13723623T PL 2844226 T3 PL2844226 T3 PL 2844226T3
Authority
PL
Poland
Prior art keywords
dessication
retention
protection
improved
ophthalmic compositions
Prior art date
Application number
PL13723623T
Other languages
English (en)
Inventor
James W. Davis
Howard Allen Ketelson
Elaine E. Campbell
David L. Meadows
Rekha Rangarajan
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL2844226T3 publication Critical patent/PL2844226T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL13723623T 2012-05-04 2013-05-03 Kompozycje okulistyczne o ulepszonej ochronie przed wysychaniem i zatrzymywaniu PL2844226T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261642901P 2012-05-04 2012-05-04
EP13723623.8A EP2844226B1 (en) 2012-05-04 2013-05-03 Ophthalmic compositions with improved dessication protection and retention
PCT/US2013/039487 WO2013166399A1 (en) 2012-05-04 2013-05-03 Ophthalmic compositions with improved dessication protection and retention

Publications (1)

Publication Number Publication Date
PL2844226T3 true PL2844226T3 (pl) 2020-04-30

Family

ID=48464107

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13723623T PL2844226T3 (pl) 2012-05-04 2013-05-03 Kompozycje okulistyczne o ulepszonej ochronie przed wysychaniem i zatrzymywaniu

Country Status (19)

Country Link
US (6) US20130296264A1 (pl)
EP (1) EP2844226B1 (pl)
KR (1) KR102076033B1 (pl)
CN (2) CN104379131A (pl)
AR (1) AR090930A1 (pl)
AU (1) AU2013256144B2 (pl)
BR (1) BR112014027582B1 (pl)
CA (1) CA2872622C (pl)
DK (1) DK2844226T3 (pl)
ES (1) ES2761373T3 (pl)
IN (1) IN2014MN02248A (pl)
MX (1) MX362266B (pl)
PH (1) PH12014502571A1 (pl)
PL (1) PL2844226T3 (pl)
PT (1) PT2844226T (pl)
RU (1) RU2659207C2 (pl)
UA (1) UA113434C2 (pl)
WO (1) WO2013166399A1 (pl)
ZA (1) ZA201408490B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9492474B2 (en) 2013-07-10 2016-11-15 Matrix Biology Institute Compositions of hyaluronan with high elasticity and uses thereof
US10245324B2 (en) * 2014-10-31 2019-04-02 Johnson & Johnson Consumer Inc. Ophthalmic composition
CN105311042B (zh) * 2015-09-07 2019-04-12 广州国宇医药科技有限公司 一种糖醇组合物在制备治疗干眼症的药物中的应用
PT3352766T (pt) 2015-09-24 2022-03-22 Matrix Biology Inst Composições de hialuronano de elevada elasticidade e processos para o seu uso
US10632202B2 (en) 2016-03-04 2020-04-28 Johnson & Johnson Consumer Inc. Preservative containing compositions
TW201938141A (zh) * 2018-02-21 2019-10-01 瑞士商諾華公司 基於脂質的眼用乳劑
TWI757773B (zh) * 2019-06-28 2022-03-11 瑞士商愛爾康公司 眼用組成物
CN114191378A (zh) * 2021-11-23 2022-03-18 温州医科大学附属眼视光医院 一种地夸磷索缓释凝胶及其制备方法与应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09227385A (ja) * 1996-02-29 1997-09-02 Ofutekusu:Kk 眼手術用補助剤
EP1348427B1 (en) 1997-07-29 2008-04-09 Alcon Laboratories, Inc. Ophthalmic compositions containing galactomannan polymers and borate
AU2004249137B2 (en) * 2003-06-13 2010-03-11 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
JP5431965B2 (ja) * 2007-02-09 2014-03-05 アルコン,インコーポレイテッド 3種のポリマーの相乗的組み合わせを含む眼科用組成物
US20090036554A1 (en) * 2007-08-01 2009-02-05 Burke Susan E Ophthalmic compositions comprising a terpene compound
US9096819B2 (en) * 2008-01-31 2015-08-04 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and an anionic biopolymer
WO2009132294A1 (en) * 2008-04-26 2009-10-29 Alcon Research, Ltd. Polymeric artificial tear system
US20100087550A1 (en) * 2008-10-06 2010-04-08 Zora Marlowe Formulations with a Tertiary Amine Oxide
EP2566447B1 (en) * 2010-05-05 2020-07-15 Alcon Inc. Stabilized ophthalmic galactomannan formulations

Also Published As

Publication number Publication date
US20210060056A1 (en) 2021-03-04
US20200138853A1 (en) 2020-05-07
IN2014MN02248A (pl) 2015-07-24
EP2844226B1 (en) 2019-11-13
PT2844226T (pt) 2019-12-16
DK2844226T3 (da) 2020-01-02
UA113434C2 (uk) 2017-01-25
MX2014013444A (es) 2015-05-11
RU2014148758A (ru) 2016-06-27
AR090930A1 (es) 2014-12-17
MX362266B (es) 2019-01-10
US20170136057A1 (en) 2017-05-18
BR112014027582B1 (pt) 2022-05-10
KR20150003868A (ko) 2015-01-09
BR112014027582A8 (pt) 2021-06-15
CN109157539A (zh) 2019-01-08
WO2013166399A1 (en) 2013-11-07
EP2844226A1 (en) 2015-03-11
US10828320B2 (en) 2020-11-10
US20220273699A1 (en) 2022-09-01
AU2013256144A1 (en) 2014-12-04
AU2013256144B2 (en) 2018-01-18
KR102076033B1 (ko) 2020-02-11
ES2761373T3 (es) 2020-05-19
ZA201408490B (en) 2016-08-31
US20230285443A1 (en) 2023-09-14
RU2659207C2 (ru) 2018-06-28
BR112014027582A2 (pt) 2017-06-27
PH12014502571A1 (en) 2015-01-21
CA2872622C (en) 2020-07-28
US11672820B2 (en) 2023-06-13
US20130296264A1 (en) 2013-11-07
US11376275B2 (en) 2022-07-05
CN104379131A (zh) 2015-02-25
CA2872622A1 (en) 2013-11-07

Similar Documents

Publication Publication Date Title
IL235436A0 (en) Anti-pcsk9 preparations and their use
IL237176A0 (en) Anticholinergic preparation that protects the nervous system and methods
ZA201408594B (en) Xylitol-based anti-mucosal compositions and related methods and compositions
IL236623B (en) Push-in earplugs
GB201318361D0 (en) Content protection
ZA201408490B (en) Ophthalmic compositions with improved dessication protection and retention
HK1216250A1 (zh) '- '-羥基-二氫麥角胺化合物及組合物
IL218364A0 (en) Responsivity enhancement for thermochromic compositions and devices
HK1212601A1 (zh) 包含沃替西汀和多奈哌齊的組合物
HK1207741A1 (en) Protection member
HK1200109A1 (en) Ophthalmic composition
GB201315350D0 (en) Methods and compositions
HK1200113A1 (en) Ophthalmic composition
EP2874641A4 (en) COMPOSITIONS INCREASING THE GLUTATHION RATE AND USES THEREOF
GB201315347D0 (en) Methods and compositions
EP2879670A4 (en) ANTIBACTERIAL COMPOSITIONS AND METHOD
EP2852662A4 (en) HERPESVIRUS COMPOSITIONS AND RELATED METHODS
SI2830587T1 (sl) Sestavek za zaščito in uravnoteženje kože
EP2800573A4 (en) OPHTHALMIC COMPOSITION
GB201210989D0 (en) Composition and device
ZA201501896B (en) Copolymers in cosmetic compositions
GB201215414D0 (en) Composition and use
IL233477A0 (en) Ophthalmic composition
GB201207855D0 (en) PIN protector